Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information communication from GlaxoSmithKline regarding Flolan (epoprostenol): Introduction of new sterile solvent with different pH; stock of current formulation to be phased out in 2017, at which stage the new formulation will be made available to order in Irish market (available from 20th March 2017).
Important Safety Information - Flolan (epoprostenol)